80370-57-6
Product Name:
Ceftiofur
Formula:
C19H17N5O7S3
Synonyms:
3-[(2-Furylcarbonyl)thio]methyl]-7-[2-(2-amino-4-thiazolyl)-2-(methoxyiminoacetamido)-3-cephem-4-carboxylic acid
Inquiry
CHEMICAL AND PHYSICAL PROPERTIES
Other Experimental Properties | Mol wt: 545.55 /Monosodium salt/ |
---|
COMPUTED DESCRIPTORS
Molecular Weight | 523.6 g/mol |
---|---|
XLogP3 | 0.2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 9 |
Exact Mass | 523.02901142 g/mol |
Monoisotopic Mass | 523.02901142 g/mol |
Topological Polar Surface Area | 256 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 945 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Ceftiofur is a third generation cephalosporin antibiotic, first described in 1987, and now used in veterinary medicine. It is marketed by pharmaceutical company Zoetis as Excenel, and is the active ingredient in that company's Specramast LC (lactating cow formula) product. It is resistant to hydrolysis by beta-lactamase, and has activity against both Gram-positive and Gram-negative bacteria. E. coli strains resistant to ceftiofur have been reported. The metabolite desfurolyceftiofur also has antibiotic activity, consequently the two compounds are measured together to monitor for antibiotic activity in the milk.